Articles

Updated 26 Oct 2026

The Deadline That Will Rebuild This Market Arrives in 2027, and No Regulator Set It

The FDA's traceability deadline moved thirty months further out while the deadline that actually forces the retrofit arrived closer — and a retailer set it, not a regulator. FSMA 204 requires records, not marks, so a straight establishment-count model yields USD 8.71 billion of hardware — 40 times the USD 217 million the rule can actually create. The larger, earlier and less negotiable date is GS1's 2027 retail target.

Updated 26 Oct 2026

The Tightest Phosphite Limit in Europe Is Set by a Certifier, Not a Regulator

A wine grape may carry 150 mg/kg of phosphonic acid and be sold as food; an organic wine may carry 1 mg/L and keep its certificate — the tighter ceiling is set by a certifier, not a regulator. And the redefinition Europe enacted on 29 April 2025 moves every reported residue by 25.5 per cent, so a 2023 certificate of analysis and a 2026 one are not comparable. All three ceilings expire with the approval on 31 July 2029, after which the default is 0.01 mg/kg: 15,000 times tighter than the wine-grape limit.

Updated 26 Oct 2026

The Sequencer Stopped Being the Product

Illumina's 2025 revenue was flat at USD 4.34 billion. Read as a headline that looks like a market stalling; read underneath, it shows growth has migrated to the high-throughput instrument, the clinical customer and a published reimbursement code. The sequencer is no longer where the money is.

Updated 25 Oct 2026

CBRS Has 420,000 Radios and Almost None of Them Are in Buildings

CBRS's celebrated 420,000 deployed radios divide out to several hundred per operator — the signature of fixed wireless access, not of buildings. In-building private cellular is roughly 1.4 per cent of the installed base, and the administrators that make those radios legal are quietly leaving.

Updated 25 Oct 2026

Canada’s PFAS Water Market Is 55 Per Cent One Department’s Cleanup Bill

Updated 25 Oct 2026

Canada’s 40 Per Cent AI Refusal Is an Answer About Products, Not Offices

Canada's 40.0 per cent "AI is not relevant" answer is a statement about what a business sells, not how it runs — and the country has no survey that asks the second question. The published figures do not even agree with each other: 40.0 per cent from Statistics Canada, 63.0 per cent implied by the federal strategy's own 78 per cent. Inside that gap sits a market worth USD 3.16 billion in 2026 and USD 8.60 billion by 2033.

Updated 25 Oct 2026

Chile’s Theft Count Fell 20 Per Cent. The Insured Rate Didn’t Move.

Chile's vehicle theft count fell 20.27 per cent between 2022 and 2025 while the insured theft rate sat flat at 0.6455 per cent for three years. The reason is the denominator: the insured parc grew 4.66 per cent on a record 4,182,519 policies sold at a 21.43 per cent lower average premium — which makes coverage, not falling crime, the largest contributor to the market's forecast.

Updated 25 Oct 2026

Half of 2025’s Orphan Approvals Rested on 5,001 Patients

Twenty-three of the FDA's 46 novel approvals in 2025 carried orphan designation — half the year's approvals on 19.2 per cent of its pivotal evidence. The median orphan programme enrolled 114 patients, nine ran on a hundred or fewer, and the whole cohort's evidence base is smaller than three non-orphan programmes enrolled in the same year.

Updated 25 Oct 2026

Nine of Twenty AI Scribes Proposed Care the Doctor Never Ordered

Ontario's Auditor General found that nine of the twenty AI documentation systems it tested fabricated content or proposed referrals and blood tests the physician never ordered — twelve transcribed a different drug than prescribed. Five weeks earlier, an independent evaluation of the same technology class reported 1.11 hours a week saved and same-day note completion up 19 points. Both documents are true, and the gap between them is where the next cycle of the Canadian market is decided.

Updated 25 Oct 2026

A Fifth of Brazil’s Approved Alternative Tests Still Use Animals

Nine of the 46 methods Brazil recognises as alternatives are animal tests, and the register is deep at the skin and empty inside the body. That gap, not the ban, is what decides which ingredient classes can be served in vitro — and why the growth curve is a step in 2027, a plateau, and a second step in 2031.

Updated 24 Oct 2026

The Tariff Made a Purchasing Decision Into a North American Content Decision

Mexico's December 2025 steel tariff puts 50 per cent on commodity flat and wire rod, but every tool-grade long product sits at 35, and finished moulds still enter at zero. The duty reaches about a sixth of a USD 142.8 million market.

Updated 24 Oct 2026

The UAE Is Not a Beauty Market; It Is a Beauty Clearing House With a Luxury Habit

USD 5.2 billion of cosmetics enters the UAE each year and USD 3.40 billion is consumed; the 37.9 per cent in between is not leakage, it is the business model. A read on why the import figure cannot be divided by a population, what the 5.3 per cent to 2033 is actually made of, and why the pallets stay in Dubai while the margin is moving to Riyadh.

Updated 24 Oct 2026

The Same Molecule Costs Three Times More Once It Carries a Monograph

A cosmetic-grade USP 38 lanolin offer sits at USD 14,700 a tonne while the blended figure implied by world trade is USD 4,556. The gap is not a data error - it is the market's actual shape, and it is why the shrinking Australian wool clip has not yet moved the price most buyers pay.

Updated 24 Oct 2026

Parts Pay 62.5 Per Cent. The Finished Flashlight Pays 25.

A finished flashlight enters the United States at 25 per cent. Its parts enter at 62.5 per cent and its cell at 53.4 per cent. That inversion is worth USD 231.75 million a year — 26.9 per cent of the entire first-sale market — and it is decided by which ten-digit code a broker selects.

Updated 24 Oct 2026

The Fuel Card Market Is Worth $10 Billion and $1 Trillion

The fuel card market is quoted at USD 10 billion and at USD 1 trillion. Both are correct answers to different questions - and the factor of 23 between two of the three perimeters is enough to overstate a supplier's addressable fee pool by everything that matters.

Updated 24 Oct 2026

Mexico’s Cat Food Market Is Twice the Size of the Market That Measures It

Retail panels see about MXN 5,000 million of Mexican cat food. The market is MXN 13.2 billion. The difference is sold by the scoop out of a twenty-kilogram sack, and every point of it that converts is worth roughly USD 7 million.

Updated 24 Oct 2026

Canada’s Modular Gap Was Never a Factory Problem

Canada builds about 2 per cent of its homes off site, against 45 per cent in Sweden — a gap normally read as a technology problem. The capacity arithmetic says otherwise: the whole country is about 36 production lines running flat out, and one ATCO line at one plant would out-produce the company's average housing book across all five. The binding constraint was a customer, and Build Canada Homes has just become one.

Updated 24 Oct 2026

A Quarter of the Barrels Carry 45.5 Per Cent of the Additive Bill

Global crude throughput is 83.5 million barrels a day and does not reach 85 by 2033. The refinery additives market still compounds at 3.52 per cent a year, because heavy sour barrels — a quarter of the volume — carry 45.5 per cent of the value at USD 0.235 a barrel against USD 0.055 for light sweet. And the bill is not paid out of a chemicals budget. It is paid out of the discount.

Updated 24 Oct 2026

The Generic Is on the Shelf, Not in the Tender

Generic apixabán reached Mexican pharmacy chains in 2026 at MXN 598 a box against MXN 2,205 for the innovator product, but an innovator amparo keeps the same generics out of public procurement. The result is two prices for one molecule, MXN 910.5 million a year left on the table, in a market that treats 76.7 per cent more patients by 2033 and earns 23.2 per cent less.

Updated 24 Oct 2026

The Backyard Is Being Built Over, Not Built In

Vancouver issued 730 laneway house permits in 2018 and will issue about 245 in 2026. That looks like a programme dying. It is the same lot, the same capital and the same permission, spent on a bigger building in the front instead of a small one in the back.